End-of-day quote
Shenzhen S.E.
03:30:00 15/05/2024 am IST
5-day change
1st Jan Change
6.64
CNY
-0.60%
-4.73%
-18.23%
Gao Yanming completed the acquisition of 6.8% in Baolingbao Biology Co.,Ltd. from Liu Zongli.
Gao Yanming signed an agreement to acquire 6.8% in Baolingbao Biology Co.,Ltd. (SZSE:002286) from Liu Zongli for approximately CNY 210 million on January 28, 2021. Under the terms, Gao Yanming will pay CNY 25 million after signing of agreement, Within three working days from the date when both parties obtain the approval documents Gao Yanming will pay CNY 135.8 million and Within six months from the date of completion Gao Yanming will pay CNY 45.1 million. After the equity transfer, Gao Yanming will hold 24,932,118 shares of Baolingbao, accounting for 6.75% of the total shares of Baolingbao Biology.
Gao Yanming completed the acquisition of 6.8% in Baolingbao Biology Co.,Ltd. (SZSE:002286) from Liu Zongli on February 18, 2021.
Baolingbao Biology Co.,Ltd. Approves Directorate Appointments
30/04
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
29/04
CI
Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2023, Payable on 08 March 2024
02/03
CI
Baolingbao Biology Co.,Ltd. Proposes Cash Dividend for 2023
08/02
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
06/02
CI
Baolingbao Biology Co.,Ltd. announced that it expects to receive CNY 300 million in funding
06/02
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
27/23/27
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
24/23/24
CI
Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2022, Payable on 20 June 2023
14/23/14
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
27/23/27
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
27/23/27
CI
Baolingbao Biology Plans $80 Million Forex Trading
18/22/18
MT
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
27/22/27
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22/22/22
CI
Baolingbao Biology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 27, 2022
21/22/21
CI
Baolingbao Biology Co.,Ltd. Announces Final Cash Dividend for the Year 2021
24/22/24
CI
Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021
30/22/30
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
28/22/28
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
27/21/27
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
19/21/19
CI
Baolingbao Biology Co.,Ltd. announced that it expects to receive CNY 711.9 million in funding from Ganzhou Zhongke Yongyu Investment Management Center (Limited Partnership), Shenzhen Zhongke Yongyu Technology Partnership Enterprise (Limited Partnership), Beijing Yongyu Investment Management Co., Ltd.
13/21/13
CI
Baolingbao Biology Co.,Ltd. Announces Cash Dividend of A Shares for the Year 2020, Payment Date on June 3, 2021
27/21/27
CI
Baolingbao Biology Co.,Ltd. Approves Cash Dividend for 2020
25/21/25
CI
Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020
30/21/30
CI
Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
28/21/28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BAOLINGBAO BIOLOGY CO., LTD. is a China-based company principally engaged in the processing, manufacture and sale of sugar products. The Company mainly provides oligosaccharide series, sugar alcohol series, high fructose syrup series, other starch sugar series, as well as starch and byproducts. The Company distributes its products in domestic markets and to overseas markets.
More about the company
1st Jan change
Capi.
-18.23% 340M -4.79% 3B -6.55% 1.85B 0.00% 1.85B -2.07% 1.15B -11.03% 1.07B +2.96% 1.01B +2.48% 933M -7.35% 912M +1.28% 819M
Sugar & Artificial Sweeteners
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**